Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Germany Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20112
20121
20132
20141
20152
20165
20176
20185
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Hoffmann-La Roche5
Merck Sharp & Dohme LLC3
AbbVie1
Amgen1
Array Biopharma, now a wholly owned subsidiary of Pfizer1
BioNTech SE1
Bristol-Myers Squibb1
Cantargia AB1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms28
Breast Neoplasms8
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Pancreatic Neoplasms5
Melanoma4
Ovarian Neoplasms3
Endometrial Neoplasms2
Neoplasms2
Stomach Neoplasms2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.